Table 4 Treatment data
SE Region | |
|---|---|
Occurrence of dose reduction | |
Gemcitabine | 60 (80) |
Nab-Paclitaxel | 60 (80) |
Reason given for dose reduction | |
Neutropenia | 23 (26) |
Comorbidity | 13 (15) |
Infection | 11 (12) |
Neuropathy | 11 (12) |
Thrombocytopenia | 8 (9) |
Liver toxicity | 6 (7) |
Anaemia | 5 (6) |